REFERENCES
1. Lostchuck E, Poulton A, Halliday J, Hui L. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016. Ultrasound Obstet Gynecol. 2019;53:503-511.
2. Wang H, Dong Z, Zhang R, Chau MHK, Yang Z, Tsang KYC, et al. Low-pass genome sequencing versus chromosomal microarray analysis: implementation in prenatal diagnosis. Genet Med. 2020;22:500-510.
3. Martin AR, Atkinson EG, Chapman SB, Stevenson A, Stroud RE, Abebe T, et al. Low-coverage sequencing cost-effectively detects known and novel variation in underrepresented populations. Am J Hum Genet. 2021;108:656-668.
4. Dong Z, Zhang J, Hu P, Chen H, Xu J, Tian Q, et al. Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach. Genet Med. 2016;18:940-948.
5. Wang J, Chen L, Zhou C, Wang L, Xie H, Xiao Y, et al. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing. Am J Obstet Gynecol. 2018;219:287 e281-287 e218.
6. Chau MHK, Wang H, Lai Y, Zhang Y, Xu F, Tang Y, et al. Low-pass genome sequencing: a validated method in clinical cytogenetics. Hum Genet. 2020;139:1403-1415.
7. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367:2175-2184.
8. Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray analysis. Fertil Steril. 2018;109:201-212.
9. Srebniak MI, Joosten M, Knapen M, Arends LR, Polak M, van Veen S, et al. Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51:445-452.
10. Lin YH, Jong YJ, Huang PC, Tsai C. Detection of copy number variants with chromosomal microarray in 10 377 pregnancies at a single laboratory. Acta Obstet Gynecol Scand. 2020;99:775-782.
11. Sagi-Dain L, Cohen Vig L, Kahana S, Yacobson S, Tenne T, Agmon-Fishman I, et al. Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies. Genet Med. 2019;21:2462-2467.
12. Jansen FA, Blumenfeld YJ, Fisher A, Cobben JM, Odibo AO, Borrell A, et al. Array comparative genomic hybridization and fetal congenital heart defects: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:27-35.
13. Wang Y, Cao L, Liang D, Meng L, Wu Y, Qiao F, et al. Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: a prospective cohort study. Am J Obstet Gynecol. 2018;218:244 e241-244 e217.
14. Society for Maternal-Fetal Medicine . Electronic address pso, Dugoff L, Norton ME, Kuller JA. The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol. 2016;215:B2-9.
15. Su J, Qin Z, Fu H, Luo J, Huang Y, Huang P, et al. The correlations of prenatal renal ultrasound abnormalities with pathogenic CNVs in a large Chinese cohort. Ultrasound Obstet Gynecol. 2021.
16. Sagi-Dain L, Maya I, Reches A, Frumkin A, Grinshpun-Cohen J, Segel R, et al. Chromosomal Microarray Analysis Results From Pregnancies With Various Ultrasonographic Anomalies. Obstet Gynecol. 2018;132:1368-1375.
17. Santirocco M, Plaja A, Rodo C, Valenzuela I, Arevalo S, Castells N, et al. Chromosomal microarray analysis in fetuses with central nervous system anomalies: An 8-year long observational study from a tertiary care university hospital. Prenat Diagn. 2021;41:123-135.
18. Sun L, Wu Q, Jiang SW, Yan Y, Wang X, Zhang J, et al. Prenatal Diagnosis of Central Nervous System Anomalies by High-Resolution Chromosomal Microarray Analysis. Biomed Res Int. 2015;2015:426379.
19. Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders. Obstet Gynecol. 2016;127:e108-e122.
20. Grande M, Jansen FA, Blumenfeld YJ, Fisher A, Odibo AO, Haak MC, et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;46:650-658.
21. Egloff M, Herve B, Quibel T, Jaillard S, Le Bouar G, Uguen K, et al. Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: a French multicenter study. Ultrasound Obstet Gynecol. 2018;52:715-721.
22. Chang Q, Yang Y, Peng Y, Liu S, Li L, Deng X, et al. Prenatal detection of chromosomal abnormalities and copy number variants in fetuses with ventriculomegaly. Eur J Paediatr Neurol. 2020;25:106-112.
23. Hu T, Tian T, Zhang Z, Wang J, Hu R, Xiao L, et al. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study. Am J Obstet Gynecol. 2021;224:516 e511-516 e516.
24. Society for Maternal-Fetal M, Electronic address pso, Fox NS, Monteagudo A, Kuller JA, Craigo S, et al. Mild fetal ventriculomegaly: diagnosis, evaluation, and management. Am J Obstet Gynecol. 2018;219:B2-B9.
25. Donnelly JC, Platt LD, Rebarber A, Zachary J, Grobman WA, Wapner RJ. Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol. 2014;124:83-90.
26. de Wit MC, Srebniak MI, Govaerts LC, Van Opstal D, Galjaard RJ, Go AT. Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature. Ultrasound Obstet Gynecol. 2014;43:139-146.
27. Chong HP, Hamilton S, Mone F, Cheung KW, Togneri FS, Morris RK, et al. Prenatal chromosomal microarray testing of fetuses with ultrasound structural anomalies: A prospective cohort study of over 1000 consecutive cases. Prenat Diagn. 2019;39:1064-1069.
28. Zhou X, Chen X, Jiang Y, Qi Q, Hao N, Liu C, et al. A Rapid PCR-Free Next-Generation Sequencing Method for the Detection of Copy Number Variations in Prenatal Samples. Life (Basel). 2021;11.
29. Liang D, Peng Y, Lv W, Deng L, Zhang Y, Li H, et al. Copy number variation sequencing for comprehensive diagnosis of chromosome disease syndromes. J Mol Diagn. 2014;16:519-526.
30. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-424.
31. Grati FR, Molina Gomes D, Ferreira JC, Dupont C, Alesi V, Gouas L, et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn. 2015;35:801-809.
32. Van Buggenhout G, Melotte C, Dutta B, Froyen G, Van Hummelen P, Marynen P, et al. Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map. J Med Genet. 2004;41:691-698.
33. Engbers H, van der Smagt JJ, van ’t Slot R, Vermeesch JR, Hochstenbach R, Poot M. Wolf-Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions. Eur J Hum Genet. 2009;17:129-132.
34. Talkowski ME, Rehm HL. Introduction of genomics into prenatal diagnostics. Lancet. 2019;393:719-721.
35. Lord J, McMullan DJ, Eberhardt RY, Rinck G, Hamilton SJ, Quinlan-Jones E, et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet. 2019;393:747-757.
36. Petrovski S, Aggarwal V, Giordano JL, Stosic M, Wou K, Bier L, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019;393:758-767.
37. Adams AD, Stover S, Rac MW. Omphalocele-What should we tell the prospective parents? Prenat Diagn. 2021;41:486-496.
38. Sinajon P, Chitayat D, Roifman M, Wasim S, Carmona S, Ryan G, et al. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 2020;55:383-390.
39. Huang RN, Chen JY, Pan H, Liu QQ. Correlation between mild fetal ventriculomegaly, chromosomal abnormalities, and copy number variations. J Matern Fetal Neonatal Med. 2022;35:4788-4796.
40. Society for Maternal-Fetal Medicine . Electronic address pso, Prabhu M, Kuller JA, Biggio JR. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013). Am J Obstet Gynecol. 2021;225:B2-B15.
41. Zhao Y, Diacou A, Johnston HR, Musfee FI, McDonald-McGinn DM, McGinn D, et al. Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects. Am J Hum Genet. 2020;106:26-40.
42. Collins RT, 2nd. Cardiovascular disease in Williams syndrome. Circulation. 2013;127:2125-2134.
43. Verbitsky M, Westland R, Perez A, Kiryluk K, Liu Q, Krithivasan P, et al. The copy number variation landscape of congenital anomalies of the kidney and urinary tract. Nat Genet. 2019;51:117-127.
44. Battaglia A, Carey JC, South ST. Wolf-Hirschhorn syndrome: A review and update. Am J Med Genet C Semin Med Genet. 2015;169:216-223.